Pittenger & Anderson Inc’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.58M | Sell |
51,245
-9,361
| -15% | -$654K | 0.13% | 125 |
|
|
2025
Q1 | $4.45M | Sell |
60,606
-135
| -0.2% | -$9.92K | 0.16% | 112 |
|
|
2024
Q4 | $3.98M | Buy |
60,741
+7,364
| +14% | +$482K | 0.14% | 117 |
|
|
2024
Q3 | $4.16M | Buy |
53,377
+6,590
| +14% | +$513K | 0.16% | 113 |
|
|
2024
Q2 | $3.65M | Buy |
46,787
+12,842
| +38% | +$1M | 0.15% | 118 |
|
|
2024
Q1 | $2.3M | Buy |
33,945
+33,790
| +21,800% | +$2.29M | 0.09% | 132 |
|
|
2023
Q4 | $10.4K | Buy |
+155
| New | +$10.4K | ﹤0.01% | 368 |
|
|
2016
Q4 | – | Sell |
-3,450
| Closed | -$113K | – | 370 |
|
|
2016
Q3 | $113K | Hold |
3,450
| – | – | 0.01% | 239 |
|
|
2016
Q2 | $104K | Sell |
3,450
-23,850
| -87% | -$719K | 0.01% | 244 |
|
|
2016
Q1 | $769K | Sell |
27,300
-12,630
| -32% | -$356K | 0.09% | 166 |
|
|
2015
Q4 | $1.36M | Hold |
39,930
| – | – | 0.17% | 140 |
|
|
2015
Q3 | $1.27M | Hold |
39,930
| – | – | 0.17% | 140 |
|
|
2015
Q2 | $1.27M | Hold |
39,930
| – | – | 0.16% | 145 |
|
|
2015
Q1 | $1.37M | Buy |
39,930
+4,950
| +14% | +$169K | 0.18% | 137 |
|
|
2014
Q4 | $1.23M | Buy |
34,980
+1,750
| +5% | +$61.6K | 0.16% | 136 |
|
|
2014
Q3 | $1.19M | Sell |
33,230
-370
| -1% | -$13.2K | 0.17% | 120 |
|
|
2014
Q2 | $1.25M | Sell |
33,600
-7,550
| -18% | -$280K | 0.18% | 118 |
|
|
2014
Q1 | $1.34M | Sell |
41,150
-1,340
| -3% | -$43.5K | 0.19% | 127 |
|
|
2013
Q4 | $1.26M | Sell |
42,490
-5,500
| -11% | -$163K | 0.18% | 130 |
|
|
2013
Q3 | $1.25M | Sell |
47,990
-1,350
| -3% | -$35.1K | 0.2% | 124 |
|
|
2013
Q2 | $1.17M | Buy |
+49,340
| New | +$1.17M | 0.2% | 125 |
|